Scientists track kids for 15 years after experimental cancer gene therapy
NCT ID NCT02315599
Summary
This study aims to understand the long-term safety of gene therapy treatments given to children with cancer. Researchers will follow up to 500 participants for 15 years to monitor for any delayed side effects that might appear months or years after treatment. The study involves regular health check-ups, blood tests, and questionnaires to track participants' health over time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Conditions
Explore the condition pages connected to this study.